Enhancing sizing accuracy in ultrasound images with an alternative ADMIRE model and dynamic range considerations.


Journal

Ultrasonics
ISSN: 1874-9968
Titre abrégé: Ultrasonics
Pays: Netherlands
ID NLM: 0050452

Informations de publication

Date de publication:
May 2023
Historique:
received: 02 09 2022
revised: 10 01 2023
accepted: 07 02 2023
pmc-release: 01 05 2024
pubmed: 17 2 2023
medline: 16 3 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

Ultrasound imaging can struggle with sizing accuracy, especially when the targets have a significantly different amplitude compared to the surrounding background. In this work, we consider the challenging task of accurately sizing hyperechoic structures, and specifically kidney stones, where accurate sizing is critical for determining medical intervention. AD-Ex, an extended alternative model of our aperture domain model image reconstruction (ADMIRE) pre-processing method, is introduced and is designed to improve clutter removal and improve sizing accuracy. We compare this method against other resolution enhancing methods such as minimum variance (MV) and generalized coherence factor (GCF), and against those methods using AD-Ex as a pre-processing tool. These methods are evaluated among patients with kidney stone disease, with the task of accurately sizing the stones against the gold standard, computed tomography (CT). Stone ROI's were selected using contour maps as reference from which the lateral stone size was estimated. Among the in vivo kidney stone cases we processed, AD-Ex+MV had the overall lowest sizing error among the methods, with an average error of 10.8% compared to the next best method AD-Ex which had an average error of 23.4%. For reference, DAS had an average error of 82.4%. Though dynamic range was evaluated to determine optimal thresholding for sizing applications, variability between stone cases was too high for any conclusions to be drawn at this time.

Identifiants

pubmed: 36796204
pii: S0041-624X(23)00028-8
doi: 10.1016/j.ultras.2023.106952
pmc: PMC10035539
mid: NIHMS1873492
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106952

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB020040
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL156034
Pays : United States
Organisme : NIH HHS
ID : S10 OD023680
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Brett Byram has patent #US20190365345A1 pending to Vanderbilt University.

Références

IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Nov;62(11):1913-27
pubmed: 26559622
IEEE Trans Ultrason Ferroelectr Freq Control. 2009 Feb;56(2):314-25
pubmed: 19251518
IEEE Trans Ultrason Ferroelectr Freq Control. 2011 Jul;58(7):1377-88
pubmed: 21768022
BJU Int. 2017 Mar;119(3):464-469
pubmed: 27459091
Urology. 2010 Aug;76(2):295-300
pubmed: 20206970
J Endourol. 2015 Feb;29(2):147-52
pubmed: 25105243
IEEE Trans Ultrason Ferroelectr Freq Control. 2007 Aug;54(8):1606-13
pubmed: 17703664
IEEE Trans Ultrason Ferroelectr Freq Control. 2009 Mar;56(3):489-506
pubmed: 19411209
Radiology. 1985 Jan;154(1):191-6
pubmed: 3880605
IEEE Trans Ultrason Ferroelectr Freq Control. 1992;39(2):262-7
pubmed: 18263145
PLoS One. 2018 Aug 28;13(8):e0203138
pubmed: 30153279
Urol Int. 2003;70(1):31-5
pubmed: 12566812
AJR Am J Roentgenol. 1996 Jan;166(1):97-101
pubmed: 8571915
IEEE Trans Ultrason Ferroelectr Freq Control. 2003 Feb;50(2):128-41
pubmed: 12625586
Ultrasound Med Biol. 2009 Feb;35(2):339-50
pubmed: 19041171
IEEE Trans Ultrason Ferroelectr Freq Control. 2020 Apr;67(4):745-759
pubmed: 31796398
Urology. 1977 Dec;10(6):544-6
pubmed: 601932
J Endourol. 2016 Sep;30(9):958-62
pubmed: 27393000
Urolithiasis. 2019 Apr;47(2):181-188
pubmed: 29356874
J Urol. 2016 Jan;195(1):171-7
pubmed: 26301788
Urology. 2016 Sep;95:67-71
pubmed: 27289025
J Ultrasound Med. 2012 Nov;31(11):1703-11
pubmed: 23091240
IEEE Trans Ultrason Ferroelectr Freq Control. 2022 Sep;69(9):2651-2662
pubmed: 35900997
JAMA. 1977 Oct 3;238(14):1519-23
pubmed: 578220
IEEE Trans Ultrason Ferroelectr Freq Control. 2017 Oct;64(10):1450-1464
pubmed: 28742033
IEEE Trans Ultrason Ferroelectr Freq Control. 2021 Mar;68(3):482-493
pubmed: 32746227
J Clin Ultrasound. 2007 Jun;35(5):256-61
pubmed: 17373690
Radiology. 2002 Jan;222(1):109-13
pubmed: 11756713
J Urol. 2016 Sep;196(3):757-62
pubmed: 27063853
AJR Am J Roentgenol. 2000 Jul;175(1):3-6
pubmed: 10882237
IEEE Trans Ultrason Ferroelectr Freq Control. 2014 Mar;61(3):428-40
pubmed: 24569248

Auteurs

Siegfried Schlunk (S)

Department of Biomedical Engineering, Vanderbilt University, Nashville, 37232, TN, USA. Electronic address: siegfried.g.schlunk@vanderbilt.edu.

Ryan Hsi (R)

Department of Urology, Vanderbilt University Medical Center, Nashville, 37232, TN, USA.

Brett Byram (B)

Department of Biomedical Engineering, Vanderbilt University, Nashville, 37232, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH